OR WAIT null SECS
August 02, 2023
The more information shared, the smoother the approval process, says Susan J. Schniepp, distinguished fellow with Regulatory Compliance Associates.
July 24, 2023
WuXi STA’s new high-potency injectable line has an annual capacity of 12 million units.
June 03, 2023
What factors do CDMOs consider vital to their success?
June 02, 2023
Manufacturers must figure out how flexible they need to be to meet the numerous new requirements of the changing therapeutic and regulatory landscapes.
May 02, 2023
In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.
April 18, 2023
Following disruption in the bio/pharmaceutical supply chain as a result of the COVID pandemic, the outsourcing industry has learned to adapt and push forward in a climate that is dynamically different.
April 03, 2023
As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.
March 02, 2023
The bio/pharma outsourcing industry continues to be integral in the development and manufacture of medicines.
February 13, 2023
The technology is designed to enable patients to self-inject biologic-based therapies at home instead of a hospital setting.
January 10, 2023
Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications